PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,652,961 | -68.2% | 86,472 | -58.4% | 0.01% | -72.4% |
| Q2 2023 | $8,330,032 | +34.4% | 207,887 | +36.9% | 0.03% | +31.8% |
| Q1 2023 | $6,195,937 | -26.7% | 151,824 | +8.1% | 0.02% | -8.3% |
| Q4 2021 | $8,452,000 | +377.8% | 140,468 | +344.6% | 0.02% | +300.0% |
| Q3 2021 | $1,769,000 | -57.6% | 31,595 | -54.1% | 0.01% | -57.1% |
| Q2 2021 | $4,173,000 | -13.4% | 68,766 | 0.0% | 0.01% | -30.0% |
| Q1 2021 | $4,820,000 | +17.1% | 68,766 | -0.0% | 0.02% | +11.1% |
| Q4 2020 | $4,115,000 | +7.1% | 68,771 | -6.1% | 0.02% | -28.0% |
| Q2 2020 | $3,841,000 | – | 73,202 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |